Insider · CIK 0001990403
Santidrian Antonio Fernandez
Files at CLDI (Calidi Biotherapeutics, Inc.). First filing -, latest -.
In brief
Santidrian Antonio Fernandez files SEC Form 4 as officer at CLDI (Calidi Biotherapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Santidrian Antonio Fernandez has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +16,000 | - | - | 16,000 | Aug 19, 2026 |
| Sep 3, 2025 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +35,000 | - | - | 35,000 | Sep 5, 2025 |
Questions about Santidrian Antonio Fernandez
Answered from the filings on this page, as of the latest one.
Is Santidrian Antonio Fernandez buying or selling?
Santidrian Antonio Fernandez has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Santidrian Antonio Fernandez's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Santidrian Antonio Fernandez has 0.
Where does Santidrian Antonio Fernandez file Form 4?
Santidrian Antonio Fernandez has filed Form 4 at CLDI (Calidi Biotherapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.